Antitissue Transglutaminase Antibodies Outside Celiac Disease
- 1 January 2002
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 34 (1) , 31-34
- https://doi.org/10.1097/00005176-200201000-00008
Abstract
Tissue transglutaminase enzyme-linked immunosorbent assay (tTG-ELISA) has recently been proposed as a simple and fast screening test for celiac disease (CD). The rate of false-positive and false-negative tests with tTG-ELISA, however, has not been definitively established. Therefore, the aim of our study was to investigate anti-tTG antibodies (TGA) not only in untreated patients with CD and in healthy controls, but also in a large group of patients with other autoimmune diseases. The presence of TGA was investigated in sera from 111 patients with untreated CD, 96 patients with other autoimmune conditions (28 with autoimmune liver disease, 46 with insulin-dependent diabetes mellitus, 10 with inflammatory bowel syndrome, 12 with type 1 polyglandular syndrome) and from 100 healthy controls using guinea pig tTG-ELISA (gp-TG/ELISA) and highly purified recombinant human tTG-ELISA (h-TG/ELISA). Western blotting with guinea pig tTG was also performed. Ninety-four patients with CD who tested positive for antiendomysial antibodies (AEA) and one who tested negative for AEA showed antibodies against the gp-TG. Among the controls, 50% of patients with autoimmune liver disease and 6.5% of patients with insulin-dependent diabetes mellitus tested positive with gp-TG/ELISA. Western blotting experiments revealed that the high rate of positive tests observed using ELISA among the control group sera is attributable to impurities in the gp-TG preparation. However, h-TG/ELISA tests were positive for the sera from all patients who tested positive for AEA and from one control who tested negative for AEA, whereas h-TG/ELISA tests were negative for all CD patients who tested negative for AEA and for other controls who tested negative for AEA. The frequency of false-negative and false-positive tests represents the major limit to the use of gp-tTG/ELISA. However, because h-TG/ELISA is both simple and fast, it could be used in large screening programs for CD.Keywords
This publication has 20 references indexed in Scilit:
- Comparative Evaluation of Serologic Tests for Celiac Disease: A European Initiative Toward StandardizationJournal of Pediatric Gastroenterology and Nutrition, 2000
- Immune reaction against the cytoskeleton in coeliac diseaseGut, 2000
- Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformisAmerican Journal of Gastroenterology, 2000
- One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase AutoantibodiesJournal of Autoimmunity, 1999
- Antibodies to Human Recombinant Tissue Transglutaminase Measured by Radioligand Assay: Evidence for High Diagnostic Sensitivity for Celiac DiseaseHormone and Metabolic Research, 1999
- Sensitivity of Antiendomysium and Antigliadin Antibodies in Untreated Celiac Disease: Disappointing in Clinical PracticeAmerican Journal of Gastroenterology, 1999
- Comparison of Tissue Transglutaminase-Specific Antibody Assays with Established Antibody Measurements for Coeliac DiseaseJournal of Autoimmunity, 1999
- Diagnosis of celiac sprueGastroenterology, 1998
- Coeliac diseaseThe Lancet, 1997
- Antigliadin and antiendomysium antibody determination for coeliac disease.Archives of Disease in Childhood, 1991